Safety and tolerability of omalizumab in patients with chronic idiopathic/spontaneous urticaria: Results from the OPTIMA study

被引：0
|
作者：
Sussman, Gordon [1 ]
Hebert, Jacques [2 ]
Gooderham, Melinda [3 ,4 ]
Gulliver, Wayne [5 ]
Lynde, Charles W. [6 ]
Papp, Kim A. [7 ]
Yang, William H. [8 ]
de Takacsy, Frederica [9 ]
Chambenoit, Olivier [9 ]
Rihakova, Lenka [9 ]
机构：
[1] Univ Toronto, Dept Med, Toronto, ON, Canada
[2] CHU Laval, Dept Med, Laval, PQ, Canada
[3] SKiN Ctr Dermatol & Prob Med Res, Peterborough, ON, Canada
[4] Queens Univ, Kingston, ON, Canada
[5] Mem Univ Newfoundland, Fac Med, St John, NF, Canada
[6] Lynde Inst Dermatol & Prob Med Res, Markham, ON, Canada
[7] Ottawa Allergy Res Corp, Ottawa, ON, Canada
[8] Univ Ottawa, Med Sch, Ottawa, ON, Canada
[9] Novartis Pharmaceut Canada, Dorval, PQ, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2018年 / 79卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
6221
引用
收藏
页码：AB250 / AB250
页数：1
相关论文
共 50 条
  • [21] Omalizumab in chronic spontaneous urticaria
    Martin Marques, Marta
    De Dios Lopez, Anna
    Jornet Montana, Sonia
    Sanchez Parada, Lucia
    Lopez Broseta, Pilar Ana
    del Estal Jimenez, Jorge
    Canela Subirada, Montserrat
    Canadell Vilarrasa, Laura
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 223 - 223
  • [22] Effect of Omalizumab on Blood Basophil Counts in Patients with Chronic Idiopathic/Spontaneous Urticaria Reply
    Schalkwijk, Joost
    van Hijum, Sacha A. F. T.
    Timmerman, Harro M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (04) : 961 - 962
  • [23] Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
    Kaplan, Allen
    Ledford, Dennis
    Ashby, Mark
    Canvin, Janice
    Zazzali, James L.
    Conner, Edward
    Veith, Joachim
    Kamath, Nikhil
    Staubach, Petra
    Jakob, Thilo
    Stirling, Robert G.
    Kuna, Piotr
    Berger, William
    Maurer, Marcus
    Rosen, Karin
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 132 (01) : 101 - 109
  • [24] Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety
    Kahveci, M.
    Soyer, O.
    Buyuktiryaki, B.
    Sekerel, B. E.
    Sahiner, U. M.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2020, 48 (04) : 368 - 373
  • [25] Omalizumab treatment in children with chronic spontaneous urticaria: Efficacy and safety
    Kahveci, M.
    Sahiner, U. M.
    Buyuktiryaki, B.
    Sekerel, B. E.
    Soyer, O.
    ALLERGY, 2019, 74 : 867 - 868
  • [26] How omalizumab came to be studied as a therapy for chronic spontaneous/idiopathic urticaria
    Kaplan, Allen P.
    Joseph, Kusumam
    Saini, Sarbjit S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2015, 3 (04): : 648 - 648
  • [27] Response to: 'Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal'
    Rosen, K.
    Maurer, M.
    Hsieh, H.
    Saini, S.
    Grattan, C.
    Gimenez-Arnau, A.
    Agarwal, S.
    Doyle, R.
    Canvin, J.
    Kaplan, A.
    Casale, T.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (01) : 15 - 16
  • [28] Omalizumab updosing in patients with chronic spontaneous urticaria and angioedema
    Denman, Sarah
    Smith, Helin
    Toolan, John
    Ford, Kate
    Wood, Phil
    Arumugakani, Gururaj
    Savic, Sinisa
    CLINICAL AND EXPERIMENTAL ALLERGY, 2018, 48 (11): : 1533 - 1534
  • [29] Omalizumab treatment response in patients with chronic spontaneous urticaria
    Knezevic, Sandra
    Dujmovic-Hasanbegovic, Katarina
    Peternel, Sandra
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 377 - 378
  • [30] The Real-Life Effectiveness and Safety of Omalizumab Updosing in Patients With Chronic Spontaneous Urticaria
    Salman, Andac
    Comert, Elif
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2019, 23 (05) : 496 - 500
12345